Dexchloropheniramine Maleate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 6 USDMF, 1 CEP/COS, 4 EU WC, 2 KDMF, 3 NDC API, 8 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 14 FDA Orange Book, 2 Europe, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML, SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 3 SPI Pharma, 4 DKSH, 2 Pharm-RX Chemical, 7 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 1 Bioplus Life Sciences, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 19 Kerry, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 18 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 26 Direct Compression, 20 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 15 Co-Processed Excipients, 14 Film Formers & Plasticizers, 13 Granulation, 12 Lubricants & Glidants, 12 Taste Masking, 10 Coating Systems & Additives, 8 Parenteral, 7 Controlled & Modified Release, 7 Chewable & Orodispersible Aids, 6 Solubilizers, 6 Topical, 4 Emulsifying Agents, 3 Rheology Modifiers, 3 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

4 NEWS #PharmaBuzz

4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 Finished Drug Prices

2 Finished Drug Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19111 / DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
chlorpheniramine(UNII: 3U6IO1965U) (chlorpheniramine - UNII:3U6IO1965U)	chlorpheniramine	8mg in 5
hydrocodone(UNII: 6YKS4Y3WQ7) (hydrocodone - UNII:6YKS4Y3WQ7)	hydrocodone	10mg in 5

Inactive Ingredients

Ingredient Name	Kremers Urban Pharmaceuticals Inc.	UCB Inc.
ascorbic acid(PQ6CK8PD0R)
D&C Yellow No. 10(35SW5USQ3G)
ETHYLCELLULOSE (10 MPA.S)(3DYK7UYZ62)
FD&C Yellow No. 6(H77VEI93A8)
high fructose corn syrup(XY6UN3QB6S)
methylparaben(A2I8C7HI9T)
polyethylene glycol 3350(G2M7P15E5P)
polysorbate 80(6OZP39ZG8H)
propylene glycol(6DC9Q167V3)
propylparaben(Z8IX2SC1OH)
STARCH, CORN(O8232NY3SJ)
sucrose(C151H8M554)
water(059QF0KO0R)
xanthan gum(TTV12P4NEE)

Drug Product Composition: Dexchloropheniramine Maleate